Journal of Allergy and Clinical Immunology
Airway smooth muscle function in asthma and COPDProliferative aspects of airway smooth muscle☆
Section snippets
Mechanisms and mediators driving growth and migration of ASM in asthma
The first report documenting increases in ASM content in asthma appeared >75 years ago.5 More than 50 years later, increased ASM content was recognized as a prominent pathological feature and major component of the structural changes that result in airway luminal narrowing in fatal6., 7., 8., 9., 10., 11., 12., 13. and nonfatal13., 14., 15. asthma. The mechanisms underlying such increases involve multiple processes that likely include both hyperplastic and hypertrophic changes. Their anatomical
Mediators driving ASM growth
The basis of excessive ASM growth is presumed to lie in stimulation of ASM by mitogenic or inflammatory stimuli. However, few reports have examined either mitogenic indices for ASM cells in human asthmatic airways or the presence of ASM mitogenic activity in the airways. Benayoun et al14 recently examined ASM proliferation by immunodetection of the nuclear antigen Ki67, which was distributed in the airway epithelium and bronchial submucosa of control volunteers or patients with varying
Migration contributing to ASM accumulation
Cellular migration is a process characterized by substantial cytoskeletal remodeling with consequent spatially directed filopodia and lamellipodia to allow increased nondirected movement (chemokinesis) or directed movement along a concentration gradient (chemotaxis). Cellular migration is a newly recognized function of ASM, identified only in the past 3 to 4 years. Although vascular smooth muscle cell migration from the media to the neointima is widely accepted as key in the pathogenesis of
Modeling of ASM growth
A variety of small animal models of asthma have been used to study ASM growth. Most studies have been performed in the Brown Norway rat, whose immune system is TH2-biased. It exhibits exuberant IgE production on active sensitization93 and typical eosinophilic airway inflammation after allergen challenge.94., 95. Repeated exposure to a sensitizing antigen such as ovalbumin results in an increase in ASM mass, assessed by morphometric analysis.96 The increase in ASM mass in the large airways
Regulation of cell cycle progression by β2-agonists
As described, the regulation of cell cycle progression by growth factors occurs through a complex set of signals that are closely regulated temporally and possibly spatially, including activation of ERK and PI3K and degradation of cdk inhibitors. Each of these key signaling cascades has been proposed as a target for regulation by asthma drugs (Fig 5).
β2-Agonists attenuate the DNA synthesis and increases in ASM cell number in response to a diverse range of mitogenic stimuli.115., 116., 117., 118.
Factors limiting the antiproliferative actions of β2-agonists and glucocorticoids
It has become apparent that different mitogens are differentially sensitive to the action of the β2-agonists and glucocorticoids. In general, thrombin and other GPCR stimuli are more sensitive to the antiproliferative actions of either glucocorticoids or β2-agonists.123 The effects of the glucocorticoids are influenced by concurrent exposure of the ASM to cytokines, such as IL-1, that induce PGE2 synthesis via increasing the expression of COX-2.125 Concurrent treatment of cells with cytokines
Summary and implications for future research
Significant overlap exists between the groups of mediators and candidate intracellular signaling intermediates that drive both the proliferation and migration of cultured ASM cells. In recent years, substantial progress has been made, and key signaling events regulating ASM growth have been elucidated. PI3K and ERK have emerged as major, but independent, signaling pathways required for ASM cell proliferation induced by a wide range of mitogens and appear to be well conserved across species. The
References (136)
Airway smooth muscle: immunomodulatory cells that modulate airway remodeling?
Respir Physiol Neurobiol
(2003)Regulation of airway smooth muscle cell immunomodulatory function: role in asthma
Respir Physiol Neurobiol
(2003)- et al.
Airway smooth muscle growth from the perspective of animal models
Respir Physiol Neurobiol
(2003) - et al.
Histamine antagonizes serotonin and growth factor-induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells
J Biol Chem
(1995) - et al.
Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta
J Biol Chem
(2003) - et al.
Mitogenic signaling pathways in airway smooth muscle
Respir Physiol Neurobiol
(2003) - et al.
Phosphoinositide 3-kinase signalling—which way to target?
Trends Pharmacol Sci
(2003) - et al.
Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells
J Biol Chem
(1999) - et al.
Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability
J Biol Chem
(1998) - et al.
Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle
J Biol Chem
(1999)
Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma
Respir Physiol Neurobiol
A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration
J Biol Chem
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain: characterization of interactions and contribution to chemotaxis
J Biol Chem
Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats
J Allergy Clin Immunol
The pathology of asthma: its absolute nature
Migration of airway smooth muscle cells
Am J Respir Cell Mol Biol
The pathology of bronchial asthma
Arch Intern Med
A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema
Thorax
Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis
Am Rev Respir Dis
Hyperplasia of bronchial smooth muscle in asthma
J Pathol
The effect of age and duration of disease on airway structure in fatal asthma
Am J Respir Crit Care Med
The mechanics of airway narrowing in asthma
Am Rev Respir Dis
Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma
Am Rev Respir Dis
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study
Am Rev Respir Dis
The structure of large and small airways in nonfatal and fatal asthma
Am Rev Respir Dis
Airway structural alterations selectively associated with severe asthma
Am J Respir Crit Care Med
Mild to moderate asthma is characterised by hyperplasia of airway smooth muscle cells without hypertrophy or acquisition of a hypercontractile phenotype
Am J Respir Crit Care Med
Quantitative measurement of bronchial muscle in men with asthma
Am Rev Respir Dis
Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles: a morphometric study
Am Rev Respir Dis
Airway smooth muscle as a target for novel anti-asthma drugs acting on airway wall remodelling
Relationship between asthma severity and PCNA expression in bronchial biopsies
Am J Respir Crit Care Med
Mild to moderate asthma is characterised by hyperplasia of airway smooth muscle cells without hypertrophy or acquisition of a hypercontractile phenotype
Am J Respir Crit Care Med
Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics
Am J Respir Cell Mol Biol
Glucocorticoids inhibit proliferation, cyclin D1 expression and retinoblastoma protein phosphorylation, but not activity of the extracellular regulated kinases (ERK) in human cultured airway smooth muscle
Am J Respir Cell Mol Biol
Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells
Am J Respir Cell Mol Biol
Airway structural alterations selectively associated to severe asthma
Am J Respir Crit Care Med
Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells
Br J Pharmacol
Cyclin D1 is required for S phase traversal in bovine tracheal myocytes
Am J Physiol
Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle
Am J Respir Crit Care Med
Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture
Br J Pharmacol
Insulin-like growth factor axis in airway smooth muscle cells
Am J Physiol
PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells
Am J Physiol
Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells
Am J Physiol
Mitogenic effect of lysosomal hydrolases on bovine tracheal myocytes in culture
J Clin Invest
alpha-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation
Am J Respir Cell Mol Biol
Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells
Am J Respir Cell Mol Biol
Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma
FASEB J
Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells
Am J Physiol
Tachykinin regulation of airway smooth muscle cell proliferation
Am J Physiol
Adrenergic receptor-mediated regulation of cultured rabbit airway smooth muscle cell proliferation
Am J Physiol
Cited by (198)
Smooth Muscle Cells
2021, Encyclopedia of Respiratory Medicine, Second EditionAsthma: Pharmacological degradation of the airway smooth muscle layer
2020, International Journal of Biochemistry and Cell BiologyThe Role of Airway Myofibroblasts in Asthma
2019, ChestTRIM37 inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells
2018, Biomedicine and Pharmacotherapy
- ☆
Disclosure of potential conflict of interest: J. G. Martin receives grants/research support from the Canadian Institute of Health Research and the Merck Medical School Grant Program. A. G. Stewart receives grants/research support from GlaxoSmithKline. S. J. Hirst, J. V. Bonacci, V. Chan, E. D. Fixman, Q. A. Hamid, B. Herszberg, J.-P. Lavoie, C. G. McVicker, L. M. Moir, T. T.-B. Nguyen, Q. Peng, and D. Ramos-Barbón have no conflict of interest to disclose.
Supported by grants from the National Asthma Campaign, United Kingdom (#00/44; 01/063; Dr Hirst et al), and from the Asthma Foundation Victoria, National Health and Medical Research Council, and GlaxoSmithKline, United Kingdom (Dr Stewart and Dr Bonacci).